Guideview >  Articles >  Trends  > 2-Iodo-5-Methylbenzoic Acid:Exports & Compliance White Paper 2026

2-Iodo-5-Methylbenzoic Acid:Exports & Compliance White Paper 2026

Explore 2-Iodo-5-Methylbenzoic Acid (CAS 52548-14-8), an iodinated benzoic acid building block for cross-coupling and medicinal chemistry. The 2026 offer highlights documented purity, compliance awareness and dependable export supply. Waite5 MIN READOctober 8, 2026
2-Iodo-5-Methylbenzoic Acid White Paper

I. Executive Summary

2-Iodo-5-methylbenzoic acid (CAS 52548-14-8, C8H7IO2, molecular weight 262.04) pairs a carboxylic-acid derivatisation handle with the most reactive aryl-halide leaving group used in modern cross-coupling. Demand is programme-driven rather than tonnage-driven: each kilogram shipped usually maps to a specific pharmaceutical, agrochemical or materials development campaign. Supply security therefore depends less on spot availability than on a supplier's ability to reproduce a defined impurity, colour and residual-metal profile batch after batch.

Two technical themes dominate qualification. The first is regiochemistry: iodination of a meta-substituted toluic framework is directed to both C2 and C6, so an uncontrolled route generates the 6-iodo and 2-iodo-3-methyl isomers, which crystallisation alone purges poorly. The second is iodine economics and stability: feedstock pricing moves with Chilean caliche and Japanese brine output, while the aryl carbon-iodine bond is photolabile, so free iodine and iodide must be controlled to hold colour and assay. Both drive cost, lead time and the analytical package a buyer should demand.

Compliance-wise this is a non-food, non-cosmetic industrial intermediate: EU REACH registration or Only-Representative coverage, CLP self-classification with a destination-language SDS, TSCA Inventory verification before US import, and, where the material enters a registered drug substance, ICH Q7 and Q11 expectations plus downstream elemental-impurity control. This paper reviews the chemistry, the capacity and pricing structure, the regulatory perimeter, ESG pressures, logistics practice and the Chinese, Indian and European supplier ecosystems, then sets out a 2026 sourcing strategy.

II. Product Deep Dive: Molecular Mechanisms and Production Evolution

2.1 Physicochemical Properties and Mechanisms

The commercial behaviour of this molecule follows from three structural facts: an iodine atom ortho to the carboxyl group, an electron-withdrawing carboxylate, and a methyl substituent blocking one flank of the ring. Together they determine acidity, coupling reactivity, isomer formation and storage stability, and they explain why the material is engineered into programmes rather than bought as a bulk commodity.

  • Acidity, hydrogen bonding and solid-state behaviour: The ortho-iodine withdraws inductively and twists the carboxyl group out of ring planarity, so the acid is markedly stronger than benzoic acid, with a pKa near 2.9 against 4.2, and it melts in the 170 to 180 °C range. That acidity simplifies salt formation and base-mediated workups, but the solid retains water and polar solvents tenaciously, which is why loss on drying and residual solvent are usually the first two specifications negotiated.
  • Photolability and colour specification: Aryl iodides absorb near-UV light and can cleave homolytically to liberate free iodine, which shows up as pink to brown discolouration and, more damaging commercially, as an iodide burden that poisons downstream palladium catalysts. Producers should therefore set an appearance or APHA colour limit, a free-iodine screen by thiosulfate or iodometric titration and a maximum iodide content, and pack under amber or opaque conditions.

2.2 Synthesis and Manufacturing Technologies

Two route classes supply the market, and the choice between them explains most of the spread in price, lead time and impurity profile.

  • Diazotisation-iodination of 2-amino-5-methylbenzoic acid (Sandmeyer-type): The anthranilic-acid route reduces 5-methyl-2-nitrobenzoic acid by catalytic hydrogenation or iron in acid, diazotises in aqueous mineral acid and quenches with iodide. Regiocontrol is absolute because the amino group fixes the position. The penalties are stoichiometric nitrite and iodide use, a nitrogen-evolution exotherm requiring controlled addition, and iodide-rich brine that must be recovered or treated.
  • Directed ortho-metalation and electrophilic iodination: Direct functionalisation of 3-methylbenzoic acid either metalates with an alkyllithium and TMEDA followed by an iodine quench, or iodinates electrophilically with iodine and an oxidant such as iodic acid, or with N-iodosuccinimide in strong acid. Metalation is selective but needs cryogenic anhydrous conditions; electrophilic iodination is cheaper but gives 2- and 6-iodo mixtures separated by fractional crystallisation, where most of the yield loss and solvent load occurs.

2.3 Core Application Matrix

  • Pharmaceutical building block and cross-coupling substrate: As an aryl iodide it enters Suzuki-Miyaura, Sonogashira, Heck and Buchwald-Hartwig couplings under milder conditions than the corresponding bromide or chloride, which matters with thermally fragile partners or low catalyst loading. The acid is usually esterified or converted to an acid chloride first, giving ortho-substituted biaryl or aryl-carboxamide cores.
  • Hypervalent-iodine precursor and oxidation catalyst: Oxidation to the iodine(III) and iodine(V) states gives iodosobenzoic and iodoxybenzoic analogues used as stoichiometric or catalytic oxidants for alcohol oxidation. The 5-methyl group tunes solubility and reactivity, which is why custom-synthesis houses catalog this acid for reagent development rather than treat it as bulk.
  • Diaryliodonium salts and metal-free arylation: Oxidation in strong acid, or reaction with arylboronic acids, gives diaryliodonium salts that transfer the aryl group without transition metals. This matters in radiochemistry and late-stage functionalisation, where metal residues must be held to single-digit ppm levels, and it is a second, higher-margin outlet for the same intermediate.

III. Global Market Supply-Demand Landscape and Export Trends

3.1 Demand Drivers and Market Shifts

Demand tracks the development pipeline rather than the macroeconomy. Growth in oncology and metabolic programmes built on ortho-substituted benzoic-acid fragments, plus a shift from bromide to iodide substrates when couplings must run cold or at low catalyst loading, has kept enquiry volumes firm while generic intermediate pricing softened. Agrochemical and electronic-materials research add smaller, cyclical volumes sold at much higher unit margin.

3.2 Capacity Distribution and Export Flows

Capacity is fragmented across multi-purpose plants rather than dedicated lines. Chinese producers in Shandong, Jiangsu and Zhejiang run campaign iodination in shared glass-lined assets; Indian CDMOs in Hyderabad, Ankleshwar and Vapi integrate the acid into API-intermediate programmes; European and North American reagent houses hold catalogue inventory. Because campaigns share equipment, lead times follow plant scheduling and cleaning validation more than raw-material availability.

3.3 Market Bifurcation and Pricing Dynamics

Prices are iodine-linked. Iodine moves with Chilean caliche and Japanese brine output and has swung substantially within a single year, so suppliers quote with short validity windows and index larger contracts to iodine. Buyers should expect a steep step between research-grade catalogue material sold on general-purpose purity and validated GMP-support intermediate carrying a full impurity, elemental and residual-solvent profile, audit trail and change control. That step, not the headline price per kilogram, determines programme cost.

IV. In-depth Analysis of Global Compliance and Regulatory Barriers

Obligations attach to the importer or its appointed representative, and they differ materially between the European Union, the United States and the case where the material enters a registered drug substance.

4.1 European Market: REACH, CLP, and Sector-Specific Directives

  • REACH registration and Only-Representative coverage: Non-EU manufacturers must appoint an EU Only Representative or sell to an importer holding the registration at the relevant tonnage band. Request the registration number, the tonnage band actually covered and confirmation that the dossier identity matches the manufactured isomer, because registrations for iodobenzoic acids are isomer-specific.
  • CLP classification, SDS and poison-centre notification: No harmonised Annex VI entry exists, so classification is self-assessed; iodinated aromatic acids are commonly notified as acute oral toxicant category 4 with skin and eye irritation and specific target-organ toxicity after single exposure. Requirements include an SDS and label in the language of the destination Member State, an updated poison-centre notification and a UFI where applicable.

4.2 North American Market: TSCA, EPA, and FDA Regulations

  • TSCA Inventory status and import documentation: Before first US import, confirm the TSCA Inventory listing and its active or inactive designation under the 2016 Lautenberg amendments; an inactive designation must be reactivated by notice before import for a commercial purpose. With no food, cosmetic or pesticide end use, FDA and EPA programme obligations generally do not attach at the intermediate stage, although accurate customs classification and a compliant SDS remain the importer's responsibility.
  • API end use: ICH Q7, Q11 and impurity control: Where the material enters a drug substance, reviewers expect GMP appropriate to the point of introduction, a defined route, starting-material justification per ICH Q11, and a specification controlling regioisomers, residual iodine species and catalyst metals. Support is normally delivered through a drug master file, an active substance master file or a CEP referenced by the finished API manufacturer.

4.3 The Critical Hurdle: Quality Control and Safety Limits

Compliance Warning: The most common failure is a certificate of analysis reporting assay and melting range but silent on the three attributes that determine downstream yield: regioisomeric purity, meaning the 2-iodo-3-methyl and 6-iodo isomers; free iodine and iodide content; and residual palladium, nickel and copper from coupling or hydrogenation steps. Under ICH Q3D, palladium is Class 2B and nickel Class 2A, both with low permitted daily exposures, while copper sits in Class 3. A supplier who cannot report these by ICP-MS, or who cannot state the residual-solvent position against ICH Q3C, should not be qualified for GMP-support supply. Catalogue material should be labelled research use only, not for human or veterinary use; there is no approved therapeutic indication for this intermediate, and an end-use declaration should be obtained before shipment.

V. Green Trade Barriers and ESG in Manufacturing

ESG review of iodinated intermediates centres on iodine stewardship, iodide-bearing effluent and solvent intensity rather than on carbon emissions alone, and European buyers increasingly treat these as qualification criteria rather than optional disclosures.

5.1 Carbon Footprint and Circular Economy

Emissions are dominated by solvent recovery, by drying a high-melting, solvent-retentive solid, and by the multi-stage crystallisations needed to purge regioisomers. Buyers seeking Scope 3 visibility should ask for energy intensity per kilogram isolated, the on-site solvent recovery fraction, and whether renewable electricity or contracted renewable steam is available; those three numbers explain most of the difference between nominally similar producers.

5.2 Sustainable Sourcing and Traceability

Iodine origin is the traceability question specific to this molecule: commercial iodine comes largely from Chilean caliche and Japanese brine operations, each with its own water, energy and community profile. Documented provenance, iodide recovery by oxidation and ion exchange on mother liquors rather than discharge, and ISO 14001 management with auditable waste manifests are now standard in European tenders, and closed-loop recovery usually also means better cost stability when iodine tightens.

VI. Supply Chain Resilience and Export Logistics

The product is a stable, high-melting crystalline solid, so logistics risk sits in light exposure, moisture uptake and documentation integrity rather than in temperature control.

6.1 Packaging Standards and Moisture/Contamination Control

  • Light-protective, moisture-barrier packaging: Standard practice is a double polyethylene liner in a fibre or HDPE drum at 25 kg, with an opaque or amber liner and, for sensitive grades, an aluminium-foil barrier bag with desiccant and oxygen absorber. Because the acid holds polar solvent and water, seal under dry conditions and record closure torque; some suppliers apply a nitrogen headspace for premium grades.
  • Avoiding metal contact and cross-campaign contamination: Bare steel or copper contact can liberate ions that poison catalysts downstream, so product-contact parts should be stainless or lined and drums should not be reused across iodine and non-iodine campaigns without validated cleaning. Ship each lot with retained samples, a tamper-evident seal number and a certificate of analysis whose lot number is printed on the drum label.

6.2 Dangerous Goods Identification and Transit Protocols

Many suppliers ship this as a non-dangerous solid for transport, but classification is data-specific and must be confirmed against the current SDS Section 14 rather than assumed; where a self-classification for acute toxicity or environmental hazard applies, the corresponding UN number, packing group and ADR, IMDG or IATA documentation follow. Shelf life is typically 24 to 36 months below 25 °C in the original closed container protected from light. Reefer transport is not normally needed; dry, ventilated stowage away from heat sources is, and GMP lots require a documented chain of custody from plant to receiving warehouse.

VII. Enterprise Global Expansion Strategy Guide

Three moves separate a reliable 2026 sourcing programme from a reactive one, and all three can be executed during supplier qualification rather than after the first failed campaign.

  1. Qualify on the impurity profile, not on the assay: Specify regioisomer content, free iodine and iodide, related substances by HPLC, residual metals by ICP-MS and residual solvents by GC headspace, with the methods named on the certificate of analysis. A 99 percent normalised-area assay is meaningless if isomers and inorganic residue are uncontrolled.
  2. Dual-source by route, not only by geography: Prefer one supplier on diazotisation-iodination and one on direct iodination or directed metalation. Because the routes generate different impurity families, route diversity survives a plant shutdown, gives a real comparison when iodine prices move, and provides a fallback if a site's permitting changes.
  3. Contract the compliance and ESG package: Make REACH or Only-Representative details, SDS language coverage, research-use-only or GMP-support status, end-use declaration, iodine provenance and solvent-recovery figures contractual deliverables, with change-control notice for any route, site or specification change. For GMP-support campaigns add an audit right and a defined analytical method transfer package.

VIII. Conclusion

This is a low-volume, high-specification intermediate whose commercial risk sits in regioselectivity, iodine economics and colour stability rather than in availability. Buyers who treat it as a commodity purchase discover the problem at the coupling step, where isomer and iodide burdens quietly consume catalyst and yield, and where a missing elemental-impurity statement can delay a regulatory submission by months.

The 2026 outlook is stable underlying demand, iodine-linked price volatility and tightening documentation expectations, particularly EU REACH and CLP currency and ICH Q3D elemental data for any API application. Route-diverse supply, contractual compliance deliverables and a genuinely analytical specification will outperform competition on headline price per kilogram.

IX. Industry Resource Connection and Supplier Ecosystem

Powered by Guidechem

This white paper is exclusively compiled by the Guidechem Intelligence Team based on global customs data, regulatory databases, and industry research. Guidechem is a leading global B2B chemical platform, dedicated to connecting global buyers with verified, high-quality manufacturers.

Guidechem Global 2-Iodo-5-Methylbenzoic Acid Supplier Ecosystem List

Relying on Guidechem's extensive global database, we have mapped the core participants in the current global 2-Iodo-5-Methylbenzoic Acid supply chain:

  • China: Shandong, Jiangsu and Zhejiang iodination cluster: Chinese producers dominate campaign supply, combining trader-sourced iodine with large multi-purpose glass-lined capacity. Strengths are scale, speed of scale-up and cost; the diligence focus is environmental permitting for iodide-bearing effluent, colour consistency between campaigns and whether the site can support GMP documentation.
  • India: Hyderabad and Gujarat API-integrated CDMO belt: Indian suppliers typically make the acid inside an API-intermediate programme, so they are strongest where the buyer needs DMF-supporting documentation, route justification and elemental-impurity data. Lead times lengthen when plant slots go to registered products, and buyers should confirm whether a quote is a development campaign or a validated repeat.
  • European Union: German, Swiss and Italian fine-chemical and reagent houses: EU supply is smaller and dearer but carries REACH registration in the importer's own name, local-language SDS and gramme-scale catalogue availability with reliable research-use-only labelling. These producers are the preferred second source for development-phase material and for buyers whose ESG reporting requires auditable iodine provenance.

Disclaimer: The content of this white paper is compiled based on public market data and regulatory information available as of 2026. Global chemical regulations are subject to dynamic adjustments. In actual export operations, enterprises must consult professional regulatory advisors or relevant competent authorities to obtain the latest compliance guidance.

Make Guideview Preferred Source on Google
Related News